GEORGE SPELLWIN'S ANNOUNCEMENTS
Enlightening Men about Anabolic Steroids and Bodybuilding for over Two Decades
 UBBFriend: Email This Page to Someone! |
 George Spellwin's ELITE FITNESS Discussion Boards
 Anabolic Discussion Board
 100 mg of test prop per week?
|
| Author | Topic: 100 mg of test prop per week? |
|
Pops Amateur Bodybuilder (Total posts: 70) |
posted April 26, 2000 10:01 PM
  
hey guys, my buddy is currently taking 100mg of brovel test 50 (50mg of test propionate per ml) once evry 7 days. i am a beleiver in small doses to be used as a slight anabolic edge, as i rely heavily on diet and nutrition blah blah blah. well anyways, what are your ANECDOTAL experiences with test propionate at this dosage? is there any chance of test suppresion? he is interested in solid long term gains.the cycle will be 100mg every 7days for 10 weeks. Please,only those with experience need respond. -Pops IP: Logged |
|
Deepsquat Pro Bodybuilder (Total posts: 560) |
posted April 26, 2000 10:15 PM
Why even bother with such a low dose? The minimum I would go is 300mg a week! This may sound like a lot to you but it is a very mild dose. IP: Logged |
|
PhatPat Amateur Bodybuilder (Total posts: 61) |
posted April 26, 2000 10:22 PM
I took Test Prop from Brovel just a little while ago. 100 mg really isnt anything, why waste your money. If you took it once every 7 days you would really be wasting your money. It is short acting. I would probably say once every 3 to 4 days at about 300mg. And that is a really small dosages. I mean it, and I am now on the end of my first cycle, I did 300mgs just like that, and it was really mild. I understand what your saying about keeping the gains and not getting too much, because I am the same way. I am the guy that takes 300 mgs of T200 a week, when others take over a 1000. So trust me 100mg is a waste of money. IP: Logged |
|
the truth Pro Bodybuilder (Total posts: 449) |
posted April 26, 2000 11:02 PM
100 mg eod minimum. Your friend is wasting his time and money. IP: Logged |
All times are ET (US) | |
 |
|
|